Showing results (841-850 of 876) with videos related to

Sort By:
Pageof 88
Neuro-Oncology|February 9, 2021
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trialMatthijs van der Meulen, Linda Dirven, Esther J J Habets, et al.
Blood Advances|August 19, 2025
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studiesConstantine S Tam, Mary Ann Anderson, Martin Simkovic, et al.
The Lancet. Oncology|January 12, 2019
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup studyJacoline E C Bromberg, Samar Issa, Katerina Bakunina, et al.
Regulatory Toxicology and Pharmacology : RTP|April 27, 2020
New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky WorkshopCatherine Mahony, Randolph S Ashton, Barbara Birk, et al.
EMBO Reports|August 16, 2022
Identification and characterization of in vitro expanded hematopoietic stem cellsJames L C Che, Daniel Bode, Iwo Kucinski, et al.
Clinical Genetics|May 20, 2025
Clinical and Neurodevelopmental Characteristics of Paralogous Gain-of-Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803Emilie Sjøstrøm, Dorota Studniarczyk, Xinyao Dou, et al.
The Journal of Trauma and Acute Care Surgery|November 9, 2017
The American Association for the Surgery of Trauma Severity Grade is valid and generalizable in adhesive small bowel obstructionMatthew C Hernandez, Nadeem N Haddad, Daniel C Cullinane, et al.
Haematologica|February 2, 2017
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14Mark Hertzberg, Maher K Gandhi, Judith Trotman, et al.
Internal Medicine Journal|September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statementMary A Anderson, Rory Bennett, Xavier Badoux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Pageof 88